Medical Microbiology articles for United Kingdom (UK)

Time frame: 1 June 2025 - 30 May 2026

View topic

Count: 172

Article ‘Count’ for Medical Microbiology.

Journal Count Share
1 0.22
Nanoscale Mechanics of FnBPB-Mediated Adhesion of Staphylococcus aureus to Skin Ligands 0.22
2 1.83
Inactivating SARS-CoV-2 Virus with MOF-Composites as Smart Face Masks 0.95
Host-Guest Inclusion Chemistry From Supramolecular Architecture Enabling Anti-Biofouling Surfaces for Oesophagus Stents 0.88
1 0.07
Estimating the effect of hepatitis C infection on multidrug-resistant tuberculosis treatment outcomes under hypothetical interventions on regimen composition and adherence 0.07
1 1.00
Species-Specific Isotope Dilution Methodology for the SI Traceable Quantification of Serum Human Ferritin Light Chain (FTL) 1.00
1 0.21
Targeting Aurora Kinases as Essential Cell-Cycle Regulators to Deliver Multi-Stage Antimalarials Against Plasmodium Falciparum 0.21
1 0.11
The Incubation Periods of Mpox Virus Clade Ib. 0.11
4 0.22
Virological characteristics of SARS-CoV-2-related coronaviruses dynamically circulating in Southeast Asia 0.01
Dynamics of natural selection preceding human viral epidemics and pandemics 0.04
EBV infection and HLA-DR15 jointly drive multiple sclerosis by myelin peptide presentation 0.06
Structural basis of poxvirus fusion regulation and anti-A16/G9 antibody-mediated neutralization and protection 0.11
1 0.63
Naturally acquired promoter variation influences Streptococcus pneumoniae infection outcomes 0.63
1 1.00
Lipid II unlocked: strategies for obtaining a major antibiotic target 1.00
1 0.33
Chemical diversification of polyprenyl quinones for mechanistic studies on menaquinone-binding peptide antibiotics 0.33
1 0.05
Pseudomonas aeruginosa in patients with Nosocomial Respiratory Infections: A secondary analysis of the European Network for ICU-Related Respiratory Infections (ENIRRIs). 0.05
10 3.04
Assessment of the Prioritization of Diagnostics in National Action Plans for Antimicrobial Resistance 0.43
Ensitrelvir for the Treatment of Hospitalized Adults With COVID-19: An International Phase 3 Randomized Placebo-controlled Trial 0.04
Predictors of Treatment Failure in Children Living With HIV Starting First-line Antiretroviral Therapy in the ODYSSEY Trial 0.28
When are uncontrolled trials in TB scientifically and ethically justified: Borrowing wisdom from early AIDS clinical trials 0.07
Retreatment With Nirmatrelvir/Ritonavir Following Return of COVID-19 Symptoms and SARS-CoV-2 Positivity 0.09
Reducing Household Tuberculosis Transmission: A Pilot Cluster-Randomized Controlled Trial 0.04
Xpert MTB/RIF® cycle threshold as a marker of TB disease severity; Implications for TB treatment stratification 0.96
Efficacy and Safety of Obeldesivir in High-Risk Nonhospitalized Patients with COVID-19 (BIRCH): a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study 0.08
Safety, Tolerability, and Immunogenicity of mRNA-1345 in Adults at Increased Risk for RSV Disease Aged 18 to 59 Years 0.05
Clinical and Microbiological Characteristics of Meningococcal Eye Infections: Retrospective National Surveillance in England, 2010–2022 1.00
1 1.00
Discovery of a novel flagellar filament system underpinning Leishmania adhesion to surfaces 1.00
1 0.06
The Disease Burden of Helicobacter pylori Beyond Gastric Cancer: Quantifying the Forgotten Potential Benefits of Mass Eradication 0.06
3 0.45
Tracking B cell immunity during perturbation of hepatitis B infection induced by treatment withdrawal 0.35
Peginterferon alpha-2a add-on to siRNA JNJ-73763989 in untreated patients with HBeAg-positive chronic hepatitis B virus (HBV) infection: the phase 2 REEF-IT study 0.07
Helicobacter pylori antibiotic resistance: a global challenge in search of solutions 0.03
1 0.71
The development of a pan-genotypic T cell vaccine against hepatitis C virus using heterologous prime-boost strategies. 0.71
4 1.44
A thiadiazolylidene-morpholine compound inhibits Pseudomonas aeruginosa by destabilizing the thiamine monophosphate kinase thiL 0.04
Minor hemolysin-coregulated proteins (Hcp) form heteromeric complexes and mediate effector secretion in Bacteroidales type VI secretion systems 0.15
Pharmacological targeting of the mycothiol cysteine ligase MshC in Mycobacterium abscessus 0.25
Hydroxamate-based inhibitors reveal structural determinants of selectivity for Plasmodium falciparum aminopeptidase P 1.00
1 0.41
Molnupiravir clinical trial simulation suggests that polymerase chain reaction underestimates antiviral potency against SARS-CoV-2 0.41
3 0.33
siRNA JNJ-73763989 decreases HBsAg and HDV RNA in NA-treated hepatitis D patients but may cause ALT flares 0.06
Single nucleotide polymorphisms in the bepirovirsen binding site have limited impact on treatment response in chronic hepatitis B 0.25
Engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor-positive cells and activates HBV-specific T cells 0.03
17 2.58
Investigation of correlates of protection against gonococcal infection by comparative immunoprofiling of responses in experimental and clinical studies 0.64
Anti-spike IgG Avidity Enhances Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2: A Prospective Study of Primary Infections and Immunizations 0.09
Age-Specific Concentrations and Seroprevalence of Antibodies Against Salmonella Enteritidis (O:9) and Salmonella Typhimurium (O:4,5) Across 3 Sites in Kenya 0.28
Severe Lower Respiratory Tract Infection in Patients With Human Bocavirus Monoinfection in Southeast China 0.07
<atl>Longitudinal Trends in Pediatric Non- iSalmonella/i Gram-negative Enterobacterales Infections at a Tertiary Care Center in West Africa, 2005-2023</atl> 0.20
Accuracy of the Phenotypic 1G Test to Detect Mycobacterium tuberculosis and Drug Resistance From Sputa in the US-Mexico Border 0.02
High Seropositivity to rK39 and Capture of Leishmania-Infected Sand Flies in Bihar and Jharkhand Emphasize the Need for Post-Elimination Surveillance of Visceral Leishmaniasis in India 0.04
False-positive malaria rapid diagnostic tests are prevalent among children under 5 years of age in Uganda 0.07
Comparison of Healthcare Resource Utilization and Disease Outcomes in Adults Hospitalized with Human Metapneumovirus and Respiratory Syncytial Virus 0.13
How Duffy Blood Group (FY) Polymorphism and Age Modulate Vivax Malaria Risk at the Community Level: A Population-based Retrospective Cohort Study in the Amazon 0.03
Leptospirosis Prevalence and Risk Factors Among Patients Presenting With Fever to 4 Healthcare Sites in Sub-Saharan Africa and South East Asia: An International Multisite Observational and Nested Case–Control Study 0.43
Epstein-Barr Virus Antibody Response Patterns in Endemic and Non-Endemic Cases of Nasopharyngeal Carcinoma 0.18
Artemisinin Partial Resistance Mutations in Zanzibar and Tanzania Suggest Regional Spread and African Origins, 2023 0.05
Virological tools fail to properly identify “unusual” hepatitis C virus subtypes resistant to direct-acting antiviral drugs in The Gambia 0.04
Risk Factors Associated With Tuberculosis Infection Among Household Contacts of Patients With Microbiologically Confirmed Pulmonary Tuberculosis in 3 High Tuberculosis Burden Countries 0.14
The Choice of Viral Load End Point in Early Phase Trials of COVID-19 Treatments Aiming to Reduce 28-Day Hospitalization and/or Death 0.05
Impact of Puberty on Immune Responses to iMycobacterium tuberculosis/i in South African Adolescents 0.13
1 1.00
Light-Activated Metal-Dependent Protein Degradation: A Heterobifunctional Ruthenium(II) Photosensitizer Targeting New Delhi Metallo-β-lactamase 1 1.00
6 1.43
Heart-nosed bat alphacoronaviruses use human CEACAM6 to enter cells 0.62
Host control of persistent Epstein–Barr virus infection 0.00
Transmission of MPXV from fire-footed rope squirrels to sooty mangabeys 0.05
Pre-assembly of biomolecular condensate seeds drives RSV replication 0.16
Population-scale sequencing resolves determinants of persistent EBV DNA 0.40
Targeting de novo purine biosynthesis for tuberculosis treatment 0.21
1 0.25
Machine learning enables scalable and systematic hierarchical virus taxonomy 0.25
51 21.47
The spatial proteome of the Plasmodium falciparum schizont illuminates the composition and evolutionary trajectories of its organelles 1.00
Towards hepatitis C elimination with integrated risk-based screening and decentralized care in Taiwan 0.05
Conserved pathogenesis of ancestral and contemporary Oropouche virus strains in a murine pregnancy model 0.21
Inhibition of host N-myristoylation compromises the infectivity of SARS-CoV-2 due to Golgi-bypassing egress 0.08
Host oxidative stress primes mycobacteria for rapid antibiotic resistance evolution 0.03
Human milk oligosaccharide mediates mutualism between Escherichia coli and Bifidobacterium bifidum 0.52
The Mycobacterium abscessus cytochrome bcc:aa3 oxidase structure paves the way for an agent targeting subunit QcrB 0.04
Activation of l-histidine biosynthesis as a new antibiotic strategy against Mycobacterium tuberculosis 0.73
Mechanisms of PfDNMT2 inhibition and PfATP6-mediated resistance to the antimalarial candidate SC83288 in Plasmodium falciparum 0.12
Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine design 0.17
The gut microbiome and metabolome associate with Schistosoma mansoni infection and cardiovascular disease risk in Uganda 0.64
Sero-genomic evidence for occult mpox exposure in healthy Nigerian adults 0.21
Efficacy of two rounds of albendazole treatment on soil-transmitted helminths in schoolchildren, Yunnan Province, China 0.06
Quantifying the bystander effect of antimicrobial use on the gut microbiome and resistome in Malawian adults 0.55
Insights into the self-assembly and interaction of sars-cov-2 fusion peptides with biomimetic plasma membranes 0.11
Rational design of next-generation filovirus vaccines combining glycoprotein stabilization and nanoparticle display with glycan modification 0.21
Assessing the risk of Guillain-Barré syndrome in older adults after bivalent RSV pre-F vaccination in England 1.00
Pre-existing and early cellular immune factors correlate with functionally complete protection against primary controlled human SARS-CoV-2 infection 0.88
Highly replicating hepatitis C virus variants emerge in immunosuppressed patients causing severe disease 0.55
LANA-specific CD4+ effector T cells accumulate at the site of KSHV infection in humanized mice 0.18
Molecular basis for multidrug efflux by an anaerobic-associated RND transporter 0.75
Genomic surveillance uncovers regional variation in HCV transmission networks in rural United States 0.02
Remission spectroscopy resolves the mechanism of action of bedaquiline within living mycobacteria 0.71
High frequency body site translocation of nosocomial 0.50
Circulation of Salmonella spp. between humans, animals and the environment in animal-owning households in Malawi 0.40
Heterogeneity in responses to ribosome-targeting antibiotics mediated by bacterial RNA repair 0.94
Greater benefits of immediate nirmatrelvir-ritonavir initiation for post-COVID outcomes: a population-based retrospective cohort study 0.05
cattle infections contain cryptic transmission-adapted bloodstream forms at low parasitaemia 1.00
Basic reproduction number varies markedly between closely related pandemic clones 0.07
The role of cytochrome bc1 inhibitors in future tuberculosis treatment regimens 0.18
Sensitive near point-of-care detection of asymptomatic and submicroscopic Plasmodium falciparum infections in African endemic countries 0.40
Enhanced virulence and stress tolerance are signatures of epidemiologically successful 0.88
A safe, T cell-inducing heterologous vaccine against elephant endotheliotropic herpesvirus in a proof-of-concept study 0.87
The assembly of a hybrid type IV secretion system by a Crohn’s disease-associated strain 0.19
Escherichia coli phylogeny drives co-amoxiclav resistance through variable expression of TEM-1 beta-lactamase 1.00
Episomal and integrated hepatitis B transcriptome mapping uncovers heterogeneity with the potential for drug-resistance 1.00
Secretins of type-two secretion systems are necessary for exopolymeric slime secretion in cyanobacteria and myxobacteria 0.67
The bactericidal FabI inhibitor Debio 1453 clears antibiotic-resistant infection in vivo 0.11
The structure of the mammalian bornavirus polymerase complex 1.00
Effect of intrapartum azithromycin on early childhood gut mycobiota development: post hoc analysis of a double-blind randomized trial 0.21
Using COVID-19 pandemic perturbation to model RSV-hMPV interactions and potential implications under RSV interventions 0.20
Microhaplotype deep sequencing assays to capture infection lineages 0.17
Acquisition of carrying extended-spectrum ß-lactamase and carbapenemase genes by hospitalised children with severe acute malnutrition in Niger 0.68
The structure of the Tad pilus alignment complex reveals a periplasmic conduit for pilus extension 0.56
T cell responses in repeated controlled human schistosome infection compared to natural exposure 0.14
Global dissemination of npmA mediated pan-aminoglycoside resistance via a mobile genetic element in Gram-positive bacteria 0.23
Prediction and characterisation of the human B cell response to a heterologous two-dose Ebola vaccine 1.00
Distinct echinocandin responses of Candida albicans and Candida auris cell walls revealed by solid-state NMR 0.09
Respiratory syncytial virus hospitalisation by chronological month of age and by birth month in infants 0.08
A P5-ATPase, FLP12, diverging from plant chloroplast lipid transporters mediates apicoplast fatty export in Toxoplasma 0.03
Variation and prognostic potential of the gut antibiotic resistome in the FINRISK 2002 cohort 0.02
4 0.40
Genomic epidemiology of the 2025 mpox epidemic in Sierra Leone 0.02
Antibiotic use and gut microbiome composition links from individual-level prescription data of 14,979 individuals 0.01
Evaluation of antimicrobial resistance governance across 193 countries to inform the 2026 Global Action Plan update 0.03
Global burden of chikungunya virus infections and the potential benefit of vaccination campaigns 0.34
1 0.25
Livestock antimicrobial use embodied in global supply chains 0.25
3 0.26
Environmental redox conditions and strain variation define phenazine-mediated antagonism in co-infecting bacteria 0.13
Systematic identification of Salmonella T6SS effectors uncovers diverse new families and lipid-targeting activities 0.09
Global siRNA screen identifies human host factors critical for SARS-CoV-2 replication and late stages of infection. 0.04
1 0.67
ATR, a DNA damage kinase, modulates DNA replication timing in Leishmania major 0.67
3 1.23
Combining demographic shifts with age-based resistance prevalence to estimate future antimicrobial resistance burden in Europe and implications for targets: A modelling study 0.88
Maternal-infant rotavirus-specific antibody kinetics to inform timing of vaccine boosting in Malawi: An observational study 0.27
Passive immunotherapy for adults hospitalized with COVID-19: An individual participant data meta-analysis of six randomized controlled trials 0.08
1 0.94
Extreme-Temperature Single-Particle Heat Engine 0.94
8 5.04
Type I interferons induced upon respiratory viral infection impair lung metastatic initiation 0.90
Use of a cytochrome P450 humanized mouse model to refine schistosomiasis drug discovery 0.96
The low-density lipoprotein receptor LDLR mediates cellular entry of nonenveloped hepatitis A virus 0.38
The prion-like characteristic of ORF3 contributes to virion release and pathogenesis of hepatitis E virus 0.06
Inhibition of fusidic acid resistance through restricting conformational flexibility in domain III of EF-G 1.00
Glycan microarray analysis of Candida-related antibodies in human and mice sera guides biomarker discovery and vaccine development 0.30
Virion proteomics of genetically intact HCMV reveals a regulator of envelope glycoprotein composition that protects against humoral immunity 0.93
A population genetic analysis of the nematode Strongyloides stercoralis in Asia shows that human infection is not a zoonosis from dogs 0.50
3 1.38
In vitro liquid-liquid phase separation induced by respiratory syncytial virus proteins and RNA 0.36
Fungal infection drives metabolic reprogramming in epithelial cells via aerobic glycolysis and an alternative TCA cycle shunt 0.87
Ultrastrong Staphylococcus aureus adhesion to human skin: Calcium as a key regulator of noncovalent interactions 0.15
2 0.13
Clinical testing of drug treatment shortening in patients with TB using PET/CT imaging of lung lesions 0.03
Modeling lesion transition dynamics to clinically characterize patients with clade I mpox in the Democratic Republic of the Congo 0.10
4 3.00
Tvp complexes support formation of the VgrG-PAAR spike during Type VI secretion system assembly 0.75
Structural basis for EtfD-mediated coupling of β-oxidation and the respiratory chain in mycobacteria 0.25
Heterochromatin epimutations impose mitochondrial dysfunction to confer antifungal resistance 1.00
A widely-occurring family of pore-forming effectors broadens the impact of the Serratia Type VI secretion system. 1.00
2 1.68
Everything is everywhere but Escherichia coli adapts to different niches 0.86
Unusual cell surfaces, pili, and archaella of iThermoplasmatales/i archaea 0.82
5 0.51
Impact of introducing RTS,S/AS01E malaria vaccine on mortality in young children in Ghana, Kenya, and Malawi: an observational evaluation of a cluster-randomised implementation programme 0.15
Safety and efficacy of the monoclonal antibody L9LS for malaria prevention in children exposed to perennial malaria transmission in Kenya: a randomised, double-blind, placebo-controlled, phase 2 trial 0.04
Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial 0.06
Feasibility of interrupting the transmission of soil-transmitted helminths: the DeWorm3 community cluster-randomised controlled trial in Benin, India, and Malawi 0.20
Epidemiology and phylogenomic characterisation of two distinct mpox outbreaks in Kinshasa, DR Congo, involving a new subclade Ia lineage: a retrospective, observational study 0.07
8 1.51
Health-economic impacts of age-targeted and sex-targeted Lassa fever vaccination in endemic regions of Nigeria, Guinea, Liberia, and Sierra Leone: a modelling study 0.35
7-year trend of timely hepatitis B birth dose vaccination coverage in The Gambia: a retrospective, population-based analysis 0.09
Effect of malaria chemoprevention for school-age children across transmission archetypes: a modelling study 0.23
Effectiveness of the RTS,S/AS01E malaria vaccine in a real-world setting over 1 year of follow-up after the three-dose primary schedule: an interim analysis of a phase 4 study in Ghana, Kenya, and Malawi 0.02
Mapping Bacillus Calmette–Guérin vaccination coverage in Africa from 1990 to 2022: a novel spatiotemporal modelling study 0.14
The impact and cost-effectiveness of pulse oximetry and oxygen on acute lower respiratory infection outcomes in children in Malawi: a modelling study 0.58
Regional and type-specific variations in the global seasonality of human parainfluenza viruses and the influence of climatic factors: a systematic review and meta-analysis 0.05
Pakistan on the Road to Zero Leprosy, an analysis of routine data for the period 1980–2022: a retrospective cohort study 0.03
1 0.90
Safety and efficacy of adjunct dexamethasone in adults with herpes simplex virus encephalitis in the UK (DexEnceph): a multicentre, observer-blind, randomised, phase 3, controlled trial 0.90
8 1.92
Phase 3 Results of Bepirovirsen Treatment for Chronic Hepatitis B Virus Infection 0.08
Ensitrelvir for Covid-19 Postexposure Prophylaxis in Household Contacts 0.13
Oral Nirmatrelvir–Ritonavir for Covid-19 in Higher-Risk Outpatients 0.58
A Phase 2 Trial of Tobevibart plus Elebsiran in Hepatitis D 0.12
Safety, Efficacy, and Immunogenicity of a Salmonella Paratyphi A Vaccine 0.81
Clesrovimab for Prevention of RSV Disease in Healthy Infants 0.04
Marburg Virus Disease in Rwanda, 2024 — Public Health and Clinical Responses 0.04
Corynebacterium diphtheriae Outbreak in Migrant Populations in Europe 0.11
3 3.00
Gestational and postnatal age define airway epithelial maturation and RSV responses during the first year of life: results of an ex-vivo/in-vitro Airway Epithelial Cell Study 1.00
Understanding risk of poor outcomes in adults hospitalised with respiratory syncytial virus infection: evidence from a multicentre UK cohort 1.00
Real-world effectiveness and safety of nirsevimab, RSV maternal vaccine and RSV vaccines for older adults: a living systematic review and meta-analysis 1.00

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.